GLP-1 drugs, a class of obesity and diabetes medications that includes Ozempic, Wegovy, Zepbound, and Mounjaro, are known to produce significant weight loss
This submission initiates a review process that typically spans 10 to 12 months, positioning potential FDA approval for late 2027 or early 2028, with commercial access likely following in the first half of 2028
Huang Y, He Y, Makarcyzk MJ, Lin H
Whether used in a beard growth oil or incorporated into other beard care products, copper peptides can help stimulate facial hair growth and improve overall beard quality
With GLP-1 medications, hunger cues become unreliable
Check our detailed guide on taking tirzepatide 2 days early